What The Papers Say: Dupilumab effectively treated patients with atopic dermatitis

Patients with moderate-to-severe atopic dermatitis treated with dupilumab as monotherapy and in combination with topical glucocorticoids displayed marked improvement in symptoms, according to recent study results.

To read more about this article, please follow this link to the Healio website.

See more eczema-related news headlines on What The Papers Say.